Clinical Trial

Efficacy of Diacylglycerol Oil on Metabolic Risk Factors in Prediabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will implement a four-week dietary intervention among middle-aged and older adults with pre-diabetes. Participants assigned to the intervention arm will replace their usual cooking oil with diacylglycerol (DAG) oil, while those in the control arm will consume colza oil. All other lifestyle behaviors will be maintained without modification. The trial will determine the impact of DAG oil consumption on glycemic regulation, lipid metabolism, and body composition in this high-risk population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-04.
Trial Details
NCT Number NCT07289880
Lead Sponsor The First Affiliated Hospital of Guangdong Pharmaceutical University
Conditions Prediabetes
Enrollment 40 participants
Start Date 2025-12-30
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-24